In previous studies, it was demonstrated that the expression of NEK2 was significantly upregulated in a variety of malignant tumors, including breast cancer [11], colorectal cancer [12], cervical cancer [13], lung cancer [14] and glioma [15]. This evidence concerns the gene NEK2 and cervical carcinoma.